Infliximab inhibits DNA repair in ultraviolet B-irradiated premalignant keratinocytes

Experimental Dermatology

Volumn 17, Issue 11, 2008, Pages 933-938

  Faurschou, Annesofie ^a   Gniadecki, Robert ^a   Wulf, Hans Christian ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Akt; Infliximab; Skin cancer; Ultraviolet radiation

Indexed keywords

CYCLOBUTANE; DNA; INFLIXIMAB; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; PROTEIN P70; PYRIMIDINE DIMER; SERINE; SYNAPTOPHYSIN; THREONINE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL SURVIVAL; CONTROLLED STUDY; DNA REPAIR; DNA SYNTHESIS INHIBITION; DOWNSTREAM PROCESSING; ENZYME INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; ULTRAVIOLET B RADIATION;

ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL CYCLE; CELL LINE; DNA REPAIR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KERATINOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PYRIMIDINE DIMERS; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS;

EID: 54049122989     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00727.x     Document Type: Article

References (34)

1. Gisondi P, Gubinelli E, Cocuroccia B, Girolomoni G. Targeting tumor necrosis factor-alpha in the therapy of psoriasis. Curr Drug Targets Inflamm Allergy 2004: 3: 175-183.
2. Tobin A M, Kirby B. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis. BioDrugs 2005: 19: 47-57.
3. Arnott C H, Scott K A, Moore R J, Robinson S C, Thompson R G, Balkwill F R. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene 2004: 23: 1902-1910.
4. Moore R J, Owens D M, Stamp G et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 1999: 5: 828-831.
5. Asher A L, Mule J J, Kasid A et al. Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors. J Immunol 1991: 146: 3227-3234.
6. Chakravarty E F, Michaud K, Wolfe F. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol 2005: 32: 2130-2135.
7. Faurschou A, Gniadecki R, Calay D, Wulf H C. TNFα impairs the S-G2/ M cell cycle checkpoint and cyclobutane pyrimidine dimer repair in premalignant skin cells: Role of the PI3K-Akt pathway. J Invest Dermatol 2008: 14 February 2008; doi:.
8. Calautti E, Li J, Saoncella S, Brissette J L, Goetinck P F. Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem 2005: 280: 32856-32865.
9. Peng X D, Xu P Z, Chen M L et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 2003: 17: 1352-1365.
10. Segrelles C, Moral M, Lara M F et al. Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 2006: 25: 1174-1185.
11. Suzuki A, Itami S, Ohishi M et al. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res 2003: 63: 674-681.
12. Altomare D A, Testa J R. Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005: 24: 7455-7464.
13. Chang F, Steelman L S, Lee J T et al. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: Potential targeting for therapeutic intervention. Leukemia 2003: 17: 1263-1293.
14. Kock A, Schwarz T, Kirnbauer R et al. Human keratinocytes are a source for tumor necrosis factor alpha: Evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990: 172: 1609-1614.
15. Schwarz A, Bhardwaj R, Aragane Y et al. Ultraviolet-B-induced apoptosis of keratinocytes: Evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J Invest Dermatol 1995: 104: 922-927.
16. Boukamp P, Peter W, Pascheberg U et al. Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss. Oncogene 1995: 11: 961-969.
17. Ren Q, Kari C, Quadros M R et al. Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor kappaB signaling. Cancer Res 2006: 66: 5209-5215.
18. Mouret S, Favier A, Beani J C, Leccia M T. Differential p53-mediated responses to solar-simulated radiation in human papillomavirus type 16-infected keratinocytes. Exp Dermatol 2007: 16: 476-484.
19. Thorn T, Gniadecki R, Petersen A B, Vicanova J, Wulf H C. Differences in activation of G2/M checkpoint in keratinocytes after genotoxic stress induced by hydrogen peroxide and ultraviolet A radiation. Free Radic Res 2001: 35: 405-416.
20. Bulavin D V, Higashimoto Y, Popoff I J et al. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 2001: 411: 102-107.
21. Chouinard N, Therrien J P, Mitchell D L et al. Repeated exposures of human skin equivalent to low doses of ultraviolet-B radiation lead to changes in cellular functions and accumulation of cyclobutane pyrimidine dimers. Biochem Cell Biol 2001: 79: 507-515.
22. You Y H, Lee D H, Yoon J H, Nakajima S, Yasui A, Pfeifer G P. Cyclobutane pyrimidine dimers are responsible for the vast majority of mutations induced by UVB irradiation in mammalian cells. J Biol Chem 2001: 276: 44688-44694.
23. Merk H F, Baron J M, Heise R et al. Concepts in molecular dermatotoxicology. Exp Dermatol 2006: 15: 692-704.
24. Courdevault S, Baudouin C, Charveron M et al. Repair of the three main types of bipyrimidine DNA photoproducts in human keratinocytes exposed to UVB and UVA radiations. DNA Repair (Amst) 2005: 4: 836-844.
25. Manning B D, Cantley L C. AKT/PKB signaling: Navigating downstream. Cell 2007: 129: 1261-1274.
26. Lisby S, Faurschou A, Gniadecki R. The autocrine TNFalpha signalling loop in keratinocytes requires atypical PKC species and NF-kappaB activation but is independent of cholesterol-enriched membrane microdomains. Biochem Pharmacol 2007: 73: 526-533.
27. Pfeifer G P, You Y H, Besaratinia A. Mutations induced by ultraviolet light. Mutat Res 2005: 571: 19-31.
28. Wang L E, Xiong P, Strom S S et al. In vitro sensitivity to ultraviolet B light and skin cancer risk: A case-control analysis. J Natl Cancer Inst 2005: 97: 1822-1831.
29. Ziegler A, Jonason A S, Leffell D J et al. Sunburn and p53 in the onset of skin cancer. Nature 1994: 372: 773-776.
30. Zhuang L, Wang B, Shinder G A, Shivji G M, Mak T W, Sauder D N. TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J Immunol 1999: 162: 1440-1447.
31. Mitoma H, Horiuchi T, Hatta N et al. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology 2005: 128: 376-392.
32. Lugering A, Schmidt M, Lugering N, Pauels H G, Domschke W, Kucharzik T. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 2001: 121: 1145-1157.
33. van den Brande J M, Braat H, Van Den Brink G R et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003: 124: 1774-1785.
34. Jinlian L, Yingbin Z, Chunbo W. p38 MAPK in regulating cellular responses to ultraviolet radiation. J Biomed Sci 2007: 14: 303-312.